David Southwell
Listed on 2 Form D filings across 2+ issuers
· Director, Executive Officer
Associated issuers
- Volastra Therapeutics, Inc. CIK 1968822 · NY
- Sensorium Therapeutics, Inc. CIK 1874823 · MA
Filings (2)
-
Volastra Therapeutics, Inc.D · 2025-09-23 · NY · Pharmaceuticals$30.1Mview →
-
Sensorium Therapeutics, Inc.D · 2025-02-12 · MA · Pharmaceuticals$38.5Mview →